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Abstract 
Background: Oridonin (ORI) could inhibit the proliferation and induce apoptosis in various 
cancer cell lines. However, the mechanism is not fully understood.  
Methods: Human prostate cancer (HPC) cells were cultured in vitro and cell viability was 
detected by the CCK-8 assay. The ultrastructure changes were observed under transmission 
electron microscope (TEM). Chemical staining with acridine orange (AO), MDC or DAPI was 
used to detect acidic vesicular organelles (AVOs) and alternation of DNA. Expression of LC3 
and P21 was detected by Western Blot. Apoptotic rates and cell cycle arrest were detected 
by FACS.  
Results: Our study demonstrated that after ORI treatment, the proliferations of human 
prostate cancer (HPC) cell lines PC-3 and LNCaP were inhibited in a concentration and 
time-dependent manner. ORI induced cell cycle arrest at the G2/M phase. A large number of 
autophagosomes with double-membrane structure and acidic vesicular organelles (AVOs) 
were detected in the cytoplasm of HPC cells treated with ORI for 24 hours. ORI resulted in 
the conversion of LC3-I to LC3-II and recruitment of LC3-II to the autophagosomal mem-
branes. Autophagy inhibitor 3-methyladenine (3-MA) reduced AVOs formation and inhibited 
LC3-I to LC3-II conversion. At 48 h, DNA fragmentation, chromatin condensation and dis-
appearance of surface microvilli were detected in ORI-treated cells. ORI induced a significant 
increase in the number of apoptotic cells (PC-3: 5.4% to 27.0%, LNCaP: 5.3% to 31.0%). 
Promoting autophagy by nutrient starvation increased cell viability, while inhibition of au-
tophagy by 3-MA promoted cell death. The expression of P21 was increased by ORI, which 
could be completely reversed by the inhibition of autophagy.  
Conclusions: Our findings indicated that autophagy occurred before the onset of apoptosis 
and protected cancer cells in ORI-treated HPC cells. P21 was involved in ORI-induced au-
tophagy and apoptosis. Our results provide an experimental basis for understand the an-
ti-tumor mechanism of ORI as treatment for prostate cancer. 
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Introduction 
Prostate cancer is one of the most common can-
cers  and  the  second  most  common  cause  of  can-
cer-related deaths in men. Orchiectomy and hormone 
therapy are used to treat prostate cancer in current 
clinical  practice.  But,  to  date,  there  is  no  effective 
therapy for hormone-independent prostate cancer[1]. 
PC-SPES, a herbal mixture, has been widely used for 
the  treatment  of  hormone-responsive  and  hor-
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mone-refractory  prostate  cancer[2].  Oridonin  (ORI), 
one of the active ingredients in PC-SPES, has various 
pharmacological  and  physiological  effects.  It  could 
inhibit the proliferation of several tumor cell lines by 
inducing cell cycle arrest and apoptosis. Thus, ORI is 
emerging as a promising anti-tumor agent. 
In recent years, ORI has been reported that ORI 
could induce autophagy in HeLa [3], MCF-7 [4], A431 
[5], L929 [6] and several other cancer cell lines. Au-
tophagy is characterized by sequestration of bulk cy-
toplasm and organelles in autophagosomes, and their 
delivery to and subsequent degradation by the cell’s 
own  lysosomal  system[7].  Microtubule-associated 
protein light chain 3 (MAP-LC3) is a critical marker 
for autophagic process. The amount of LC3-II or the 
ratio of LC3-II to LC3-I can reflect the autophagic ac-
tivity. 
Autophagy  plays  an  important  role  in  many 
physiological  processes,  including  the  response  to 
starvation, cell growth control, and anti-aging mech-
anisms[8]. Excessive autophagy may, however, lead 
to cell death referred to as type II programmed cell 
death[9]. So, autophagy has possible roles in cell sur-
vival and death. The activation of autophagy to in-
hibit cell proliferation would be an important molec-
ular mechanism for many anti-tumor drugs. Previous 
studies have reported that the autophagic capacity of 
cancer cell lines is lower than their normal counter-
parts. In fact, studies of carcinogen-induced pancre-
atic cancer in rats have shown that pancreatic adeno-
carcinoma cells have lower autophagic activity during 
tumor progression[10]. On the other hand, autophagy 
can act as a mechanism of cell survival during starva-
tion. In addition, autophagy is activated as a defense 
mechanism  in  response  to  many  cancer  therapeu-
tics[11].  
The P21 gene has been widely studied as an an-
ti-tumor gene. It is regulated directly by the P53 gene, 
and  involved  in  the  P53-mediated  DNA-damaging 
response.  In  addition,  P21  is  also  known  as  a  cy-
clin-dependent kinase (CDK) inhibitor, and can arrest 
cell cycle by inhibiting the formation of cyclin-CDK 
complex. Tasdemir et al. have suggested the role of 
P53 in the regulation of autophagy[12]. However, the 
relationship between P21 and autophagy is still not 
understood.  
In  the  present  study,  we  detected  the 
ORI-induced autophagy and the role of autophagy in 
cell  death  in  PC-3  (androgen-independent)  and 
LNCaP  (androgen-dependent)  prostate  cancer  cell 
lines. The expression levels of P21 were investigated 
to  elucidate  the  relation  of  ORI-induced  autophagy 
and apoptosis in prostate cancer.  
Materials and Methods 
Reagent 
ORI  was  purchased  from  Wuhan  Botanical 
Garden, Chinese Academy of Sciences. Cell Counting 
Kit-8  was  obtained  from  Dojindo  Laboratories  (Ku-
mamoto,  Japan).  Acridine  orange  (AO),  mono-
dansylcadervarine  (MDC),  4,6-diamidino-2- 
phenylindole  (DAPI),  3-methyladenine  (3-MA)  and 
rabbit polyclonal antibody against LC3 were obtained 
from Sigma (St. Louis, USA). Mouse monoclonal an-
tibody  against  GAPDH  and  rabbit  polyclonal  anti-
body  against  P21  were  purchased  from  Santa  Cruz 
Biotechnology (Santa Cruz, CA, USA). Lipofectamine 
2000  was  obtained  from  Invitrogen  (Carlsbad,  CA, 
USA).  Annexin  V-FITC  Kit  was  purchased  from 
Bender MedSystems (Vienna, Austria). 
Cell Lines and Cell Culture 
PC-3 and LNCaP cell lines were purchased from 
ATCC, and were cultured in F12 (GIBCO) and DMEM 
(HyClone) respectively, both supplemented with 10% 
(v/v)  non-heat-inactivated  fetal  bovine  serum  (FBS, 
from  ExCell  Biology)  and  100U/L  penicil-
lin-streptomycin.  Each  cell  line  was  maintained  at 
37°C in an atmosphere of 5% CO2. Stock solution of 
ORI was prepared in DMSO at the concentration of 
100mmol/L,  and  an  equal  volume  of  DMSO  was 
added to the control. 
The CCK-8 Assay 
Cell suspension of 100 μl was dispensed (1×104 
cells/  well)  in  96-well  plates.  The  plates  were 
pre-incubated for 24 h, followed by the treatments of 
either  DMSO  (control)  or  various  concentrations  of 
ORI for 6, 12, 24, or 48 h, and added 10 μl of CCK-8 
solution  (Dojindo  Laboratories)  to  each  well  of  the 
plate. Incubate the plate for 1 h in the incubator. The 
absorbance was measured at 450 nm using a micro-
plate spectrophotometer (BIO-RAD xMark). 
DAPI Staining 
ORI-treated cells in 96-well plate were fixed with 
4% paraformaldehyde for 10 min at 37°C, and then 
stained  with  DAPI  for  10  min,  observed  under  the 
fluorescence microscope (OLYMPUS IX71).  
Transmission Electron Microscopy (TEM) 
Analysis 
TEM analysis was performed as described pre-
viously[13]. Briefly, cells were harvested after treat-
ment of DMSO (control) or ORI, fixed in ice-cold 2.5% 
glutaraldehyde in PBS (pH 7.3) for 2 h, post-fixed in 
1% osmium retraoxide and dehydrated in a graded Int. J. Biol. Sci. 2012, 8 
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series of ethanol (50-100%) and acetone, and embed-
ded in Epon 812. Semithin sections were cut, double 
stained with uranyl acetate and lead citrate, and ex-
amined on Philips TECNAI 10 TEM.  
FACS Analysis of Apoptosis and Cell Cycle 
Arrest  
Cells  were  seeded  onto  6-well  plate  and  incu-
bated overnight. The cells were treated with DMSO or 
ORI for 24 or 48 h and collected. For apoptotic analy-
sis, cells were washed in  PBS, and re-suspended in 
pre-diluted binding buffer in a density of 2-5105/ml. 
Cell suspension of 195 μl was taken and added 5 μl 
Annexin  V-FITC.  After  incubated  10  min  at  room 
temperature, cells were washed and suspended in 190 
μl binding buffer. Then added 10 μl of the propidium 
iodide [PI] (20 μg/ml) and analyzed by FAC Scan. For 
cell cycle analysis, cells were washed and fixed with 
ice-cold  75%  (v/v)  ethanol  at  -20°C  for  2  h,  then 
stained with PI at the concentration of 50 μg/mL in 
the presence of RNase A (100 μg/mL). DNA content 
was analyzed.  
Vital Staining with AO or MDC 
ORI-treated cells cultured in 96-well plate were 
stained with AO (5 μg/mL) or MDC (0.05 mmol/L) 
directly for 10 min at 37°C, and then observed under 
the fluorescence microscope (OLYMPUS IX71).  
Western Blot Analysis 
Following  the  different  treatments,  cells  were 
lysed  with  lysing  solution  containing  150  mmol/L 
NaCl, 50 mmol/L Tris-HCl (pH 8.0), 0.5% deoxycholic 
acid,  1%NP-40,  0.1%  SDS  and  protease  inhibitor 
cocktail (0.1 mmol/L PMSF, 1 mmol/L Na3VO4, 100 
μmol/L lepeptin) on ice for 30 min. Cell lysates was 
cleared by centrifugation at 12000 rpm for 15 min at 
4°C.  The  protein  concentration  was  determined  by 
Bicinchoninic  acid  protein  assay  kit  (Pierce).  Equal 
proteins  were  separated  by  12%  SDS-PAGE  and 
transferred  to  polyvinylidene  difluoride  (PVDF) 
membrane (Millipore). After blocked with a solution 
containing 10 mmol/L Tris, 150 mmol/L NaCl, 0.1% 
Tween 20 (TBS-T) and 5% non-fat dry milk for 4 h at 
room temperature, the membrane was incubated with 
the  respective  primary  antibody  at  4°C  overnight. 
Then it was treated with appropriate secondary anti-
body for 2 h at room temperature. The immunoblots 
were visualized by enhanced chemiluminescent sub-
strate (Thermo).  
Transient Transfection and Confocal Micros-
copy Analysis 
The  tandem  fluorescent-tagged  LC3  construct 
(tfLC3),  which  has  been  described  previously,  was 
provided by Dr. Tamotsu Yoshimori (national insti-
tute of Genetics, Shizuoka-ken, Japan). The transient 
transfection was performed using Lipofectamine Plus 
reagents (Invitrogen) according to the manufacturer’s 
protocol.  The  transfected  cells  were  examined  by  a 
confocal microscopy (Zeiss lsm-510). 
Statistical Analysis 
All data and results presented were confirmed in 
at  least  three  independent  experiments,  unless  oth-
erwise indicated. The data are expressed as mean ± 
S.D. Student’s t-distribution probability density func-
tion (Statistical Package for Social Sciences for Win-
dows) was used for calculation of P-value. Differences 
were considered significant at P<0.05. 
Results 
Cytotoxicity of ORI in HPC Cells 
After  treatment  with  different  concentrations 
(10, 25, 40, 60, 100 μmol/L) at different times (12, 24, 
48 and 72 h), the anti-tumor activity of ORI was as-
sessed in PC-3 and LNCaP HPC cell lines by CCK-8 
kit. ORI induced cell growth inhibition in a concen-
tration and time-dependent manner in both cell lines, 
while  relative  concentration  of  DMSO  (≤  0.1%)  has 
little influence on cell proliferation. The IC50 of ORI 
treatment at 48 h for PC-3 and LNCAP cell lines were 
approximately 25μmol/L (Fig.1A).  
Under phase-contrast microscope, the number of 
ORI-treated HPC cells decreased at 24 h. At 48 h, it 
decreased significantly and the majority of cells be-
came rounded and smaller in size (Fig. 1B). The cell 
cycle was analyzed by PI staining and FACS. In PC-3 
cells, ORI treatment for 24 h induced an increase in 
the  cell  numbers  at  G2/M  phase  (21.04±3.76%  to 
37.50±7.43%).  Similar cell cycle arrest  was also de-
tected in LNCaP cells (11.88±0.64% to 23.04±1.38%). 
Meanwhile, sub-G1 peak was detected neither in PC-3 
nor in LNCaP cells (Fig. 1C, Table 1).  
Change of LC3 Protein Expression 
The tfLC3 plasmid was successfully transfected 
into  PC-3  cells  and  fluorescent  changes  in  the  cells 
were observed by laser scanning confocal microscopy 
before and after ORI treatment. The results showed 
that GFP-LC-3 protein was evenly distributed in the 
cytoplasm in untreated PC-3 cells.  While, treatment 
with  ORI for 1 h  produced a punctuate pattern for 
GFP-LC3  fluorescence.  The  spots  were  further  en-
hanced after 4 h (Fig. 2A). Int. J. Biol. Sci. 2012, 8 
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Fig.1. ORI inhibited the proliferation of HPC cells. A: Cell viability assay. HPC cells in 96-well plates were treated with different con-
centrations of ORI or DMSO for different time, and cell viability was determined using the CCK-8 assay (10 μl/well CCK-8 solution for 
1 h). B: ORI reduced cell density. Cells in 96-well plate were treated by ORI or DMSO for 24 or 48 h, and observed under phase-contrast 
microscope (×200). C: Cell cycle was arrested at G2/M phase by ORI. Cells treated with 25 μmol/L ORI or DMSO for 24 h were fixed 
with ice-cold 75% ethanol (-20°C for 2 h), and stained with PI solution of 50 μg/ml. DNA content was analyzed by FACS. The data in A and 
C are presented as means ± S.D. from three independent experiments. Int. J. Biol. Sci. 2012, 8 
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Fig.2. ORI treatment induced autophagy in HPC cells. A: LC3II protein was recruited to autophagosomsal membranes. After transfected 
with tfLC3 plasmid, PC-3 cells in 24-well plates were treated with ORI (25 μmol/L) and examined by confocal microscopy (×400). A 
punctuate pattern for GFP-LC3 fluorescence was observed. B: ORI increased LC3 expression. Cells were treated with ORI (25 μmol/L) 
or DMSO for 12, 24 or 48 h, then collected and subject to Western Blot. C: Increase of LC3 level was inhibited by 3-MA. Cells were 
treated by ORI (25 μmol/L) with or without 3-MA (5 mmol/L) for 24 h, then the expression of LC3 protein were detected by Western 
Blot. The data in B and C were from three independent experiments. 
 
Table 1 Cell cycle was arrested at G2/M phase by ORI. 
  PC-3 Cells  LNCap Cells 
  DMSO    ORI    DMSO    ORI   
  Mean  S.D.    Mean  S.D.  p-value  Mean  S.D.    Mean  S.D.  p-value 
G1/G0  57.10  8.94    38.06  4.44  0.088  76.92  1.74    66.05  1.05  0.001** 
G2/M  21.04  3.76    37.50  7.43  0.200  11.88  3.76    23.04  1.38  0.000** 
S  27.12  4.47    24.44  3.13  0.696  11.20  1.10    10.82  0.92  0.666 
Cells were treated by ORI(25μmol/L) or DMSO for 24h, stained by PI and detected by FACS. The data in Table 1 were from three inde-
pendent experiments and analyzed using Student’s test(*,P<0.05;**,P<0.01). 
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Levels  of  LC3-I  and  LC3-II  in  PC-3  cells  were 
up-regulated after 12 h of ORI treatment, and reached 
maximum at 24 h. At 48 h, the levels of both LC3-I and 
LC3-II were reduced, but still remained higher than 
the controls. Similar changes of LC3 were detected in 
ORI-treated LNCaP cells (Fig.2B). These results sug-
gested that ORI treatment for 24 h could induce high 
expressions of LC3-I and II.  
We further examined the influence of 3-MA in 
ORI-induced increase of LC3 in HPC cells. The results 
showed that the levels of LC3 expression in ORI and 
3-MA co-treated cells were lower than that of the cells 
treated with ORI alone, but remained higher than the 
controls. The treatment of 3-MA alone did not change 
the expression of LC3 (Fig. 2C).  
Change of Cell Ultra-structure in HPC cells 
No changes in cells nuclei and membranes were 
observed in ORI-treated PC-3 cells at 24 h. But inter-
estingly,  the  appearance  of  a  large  number  of  free 
membrane structures and double-membrane vacuoles 
were found in the cytoplasm. These free membrane 
structures  resembled  pre-autophagosomal  structure 
(PAS), and some of the later vacuoles resembled au-
tophagosomes. After 48 h, typical apoptotic changes 
with chromatin condensation and nuclear fragmenta-
tion were observed in ORI-treated cells (Fig.3A). The 
nuclei were normal and there was no chromatin con-
densation in the ORI-treated LNCaP cells for 24 h (Fig. 
4). But, the formation of a large number of vacuoles 
indicated  cytoplasmic  vacuolization.  Autophago-
somes  were  also  observed  in  the  cytoplasm,  which 
contained portions of cytosol and organelles, such as 
endoplasmic  reticulum  (ER)  and  mitochondria  (Fig. 
3B). 
Detection of AVOs 
By AO staining, red fluorescent spots appeared 
on ORI-treated PC-3 cells, while the control cells, and 
the  cells  co-treated  with  5  mmol/L  3-MA  and  ORI 
showed mainly green cytoplasmic fluorescence. Sim-
ilarly, prominent accumulation of autophagic specific 
staining  MDC  was  observed  around  the  nuclei  in 
ORI-treated PC-3 cells (Fig.4). 
 
 
 
 
Fig.3.  Formation  of  autophago-
somes  was  induced  by  ORI  in 
HPC  cells.  Cells  were  treated 
with ORI (25 μmol/L) or DMSO, 
and  examined  under  TEM  A: 
Changes  of  ultra-structure  in 
PC-3  cells  induced  by  ORI.  (a) 
Controls, (b) Cells treated with 
ORI  for 24  h,  (c)  Cells  treated 
with  ORI  for  48  h,  (d) 
ORI-induced  PAS,  (e) 
ORI-induced  autophagosome 
(arrows).  B:  Changes  of  ultra-
structure  in  LNCaP  cells.  Cells 
were treated with DMSO or ORI 
(25  μmol/L) for 24  h. (a)  Con-
trols,  (b)  ORI-treated  cells,  (c) 
Cytoplasmic  vacuolization,  (d) 
Autophagosome with cytoplasmic 
material,  (e)  Autophagosome 
with ER, (f) PAS with mitochon-
dria (arrows). 
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Fig.4. Accumulation of AVOs induced by ORI treatment (×200). Cells in 96-well plate were treated by ORI (25 μmol/L) with or without 
3-MA (5 mmol/L) for 24 h, stained with AO (5 μg/mL) or MDC (0.05 mmol/L) for 10 min, then observed. Red fluorescent spots of AO and 
prominent accumulations of MDC were observed in both ORI-treated cells (arrows). 
 
Autophagy Played a Protective Role in 
ORI-treated PC-3 Cells 
 Cell  proliferation  was  not  affected  in  cells 
treated with starvation (in EBSS medium) for 1 or 2 h. 
When the time was extended to 4 h, cell viability re-
duced to 74.54% (Fig.5A, P<0.01). Similarly, the effects 
of 1 or 2 mmol/L 3-MA on cell proliferation were very 
small. As the concentration increased to 5 mmol/L, 
cell viability decreased to 79.57% (Fig.5B, P<0.05). The 
viability of cells treated with ORI alone was 80.75% 
compared  to  the  control  group.  Pretreatment  with 
starvation for 2 h and  treatment with ORI for 24 h 
increased cell viability to 91.40%. Combined treatment 
of ORI and 3-MA (2 mmol/L) reduced the viability to 
65.56%, indicating that autophagy could play a pro-
tective role in ORI-treated PC-3 cells (Fig.5C).  
 
 
Fig.5. Protective role of autophagy in ORI-treated PC-3 cells. A: 
Inhibition of proliferation induced by starvation. Cells were cul-
tured in EBSS for different times (1, 2, 4, and 7 h). B: Cytotoxicity 
of 3-MA. Cells in 96-well plates were treated by 3-MA in different 
concentrations (1, 2, 5 and 10 mmol/L) for 24 h. C: Autophagy 
protected cells survival. Cells in 96-well plate were treated with 
media containing 25 μmol/L ORI, or ORI plus 2 mmol/L 3-MA, or 
pre-cultured in EBSS for 2 h then treated by ORI in full media for 
24 h. Cell viabilities were measured by the CCK-8 assay. The data 
were presented as means ± S.D. from 3 independent experiments 
(
*P<0.05, 
**P<0.01). 
 Int. J. Biol. Sci. 2012, 8 
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Detection of Apoptosis in ORI-treated HPC 
Cells 
By DAPI staining, PC-3 cells treated with DMSO 
or ORI at 24 h exhibited  normal  nuclei, but typical 
apoptotic changes with chromatin condensation and 
nuclear fragmentation were observed at 48 h (Fig.6A). 
The  levels  of  ORI-induced  apoptosis  in  HPC  cells 
were determined by Annexin V-FITC/PI staining and 
FACS. In PC-3 cells, treatment with 25 µmol/L ORI 
for  24  h  caused  only  5.4%  of  the  cells  to  undergo 
apoptosis  (2.25%  for  control).  In  spite  of  this,  ORI 
treatment  for  48  h  resulted  in  an  approximately 
4.2-fold (27.0%) increase of the apoptotic rate (2.94% 
for controls). Similar changes of apoptotic rates were 
detected  in  LNCaP  cells,  and  the  apoptotic  rate  in-
creased from 5.3% for 24 h to 31.0% for 48 h (Fig. 6B). 
 
 
 
Fig.6. ORI induced apoptosis in HPC cells after longer treatment. A: Longer treatment with ORI resulted in chromatin condensation and 
nuclear fragmentation (arrows, ×200). PC-3 cells in 96-well plates were treated with 25 μmol/L ORI for 24 or 48 h, fixed and stained with 
DAPI (2 μg/mL), and observed for nuclear alterations under the fluorescence microscope. B: The apoptotic rates were evidently in-
creased after longer treatment with ORI. Cells in 6-well plates were treated with ORI (25 μmol/L) for 24 or 48 h, stained with Annexin 
V-FITC for 10 min and PI for 10 min, then analyzed by FACS. (
*P<0.05, 
**P<0.01). 
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Fig.7. Inhibition of autophagy blocked the augment of P21 induced by ORI. A: The expression of P21 was up-regulated by ORI. Cells were 
treated with ORI (25 μmol/L) for 12, 24 or 48 h, and detected by Western Blot. B: ORI-induced augment of P21 protein was blocked by 
3-MA. Cells were treated by ORI with or without 3-MA (5 mmol/L), and subjected to Western Blot. The data are from three independent 
experiments. 
 
Change in P21 Protein Expression 
The P21 protein expression in ORI-treated PC-3 
cells increased by 4.16, 12.32, and 9.48 folds at 12 h, 24 
h,  and  48  h,  respectively,  compared  to  the  control 
group. Also, the P21 protein expression in ORI-treated 
LNCaP cells increased by 7.74, 18.39, and 12.80 folds 
at 12 h, 24 h, and 48 h, respectively, compared to the 
control  group.  Co-treatment  with  5  mmol/L  3-MA 
and ORI could reduce the increase in P21 expression 
(Fig. 7).  
Discussion 
ORI is an active diterpenoid compound extract-
ed  from  the  Chinese  traditional  medicine  Rabdosia 
rubescens. It has the potential to develop into a highly 
effective anti-tumor chemotherapeutic drug. ORI has 
shown anti-tumor effects against a variety of human 
cancers such as, lung and breast cancers, and leuke-
mia[14].  In  the  present  study,  we  found  that  ORI 
could  inhibit  the  proliferation  of  both  PC-3  and 
LNCaP prostate cancer cell lines  and  induce  G2/M 
phase cell cycle  arrest.  ORI treatment  increased the 
expression  of  LC3  and  induced  the  formation  of 
AVOs in HPC cells. Meanwhile, the expression of P21 
was increased, which could be blocked by 3-MA.  
LC3 is recognized as the most common autoph-
agy marker. Sometimes, because of LC3-I instability, 
LC3-II is typically used as a marker for autophago-
some formation. We detected the intracellular locali-
zation and expression of the LC3 protein, and found 
that  ORI  significantly  increased  the  expressions  of 
both LC3-I and LC3-II, and promoted the conversion 
of water-soluble LC3-I to lipidated LC3-II, which was 
recruited to autophagosomsal membranes. Although 
ORI has been reported to induce PC-3 cells autophagy 
and  promote  LC3  expression[15],  but  in  this  study, 
similar  results  were  observed  in  both  PC-3  and 
LNCaP cells.  Our results further suggested that the 
induction of autophagy in HPC cells were unlikely to 
be cell type-specific. Besides, it is evident that the level 
of ORI-induced autophagy reached its peak at 24 h 
after drug treatment, but began to decline thereafter.  
In recent years, the autophagic process has been 
observed in response to various cancer-relevant stim-
uli,  including  radiation[16],  ceramide[17],  rapamy-
cin[18], and arsenic trioxide[19]. In the present study, 
a  large  number  of  double-membrane 
autophagosomes  and  PAS  were  observed  in  both 
PC-3  and  LNCaP  cell  lines  treated  with  ORI.  The 
mature  autophagosome  fuses  with  lysosome  to  be-
come  autolysosome,  which  is  one  structure  of  the 
AVOs. The fluorescent dyes AO and MDC were used 
as specific traces for AVOs. AO dye in acidic site flu-
oresced  bright  red  and  apparent  accumulation  of 
MDC in the cytoplasm indicated the accumulation of 
AVOs.  
In addition, we co-treated HPC cells with 3-MA 
and ORI, and found that 3-MA could reverse the ac-
cumulation of MDC and AO in acidic organelles and 
reduce  the  expression  levels  of  LC3-II.  Considering 
the conserved positive role of Class III phosphatidyl-
inositol  3-kinase  (PI3K)  in  the  autophagic  process, 
3-MA as a PI3K inhibitor, has been reported as a spe-
cific autophagy inhibitor. It inhibited or blocked the 
formation of autophagosomes by blocking the Class Int. J. Biol. Sci. 2012, 8 
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III PI3K/beclin 1 signal pathway[20, 21]. All these re-
sults  indicated  that  3-MA  could  specifically  inhibit 
ORI-induced autophagy in HPC cells by inhibiting the 
increase  of  LC3.  Interestingly,  it  has  been  reported 
that  3-MA  has  dual  roles  in  the  modulation  of  au-
tophagy. 3-MA has been found to promote autophagy 
flux when treated under nutrient-rich condition with 
a  prolonged  period  of  treatment,  whereas  it  is  still 
capable  of  suppressing  starvation-induced  autopha-
gy[22]. There are two explanations for this contradic-
tion. First, ORI is able to inactivate Class I PI3K/Akt 
pathway[23, 24]. The blockade of Class I PI3K/PKB 
pathway weakens the positive effect of 3-MA on au-
tophagy. Second, class III PI3K is associated with the 
protein Beclin 1, another marker of autophagy. Low 
expression of Beclin 1 in various cancer cells has been 
detected[21], thus, the suppressive effect of 3-MA on 
autophagy  is  weakened  under  nutrient-rich  condi-
tions.  In  oridonin-induced  Hela  cells,  pretreatment 
with  3-MA  has  been  shown  to  decrease  the  au-
tophagic ratio accompanied with downregulation of 
the protein expression of Beclin 1 [25]. Further studies 
are  still  required  to  understand  the  mechanism  of 
3-MA as an inhibitor of ORI-induced autophagy.  
Our research also showed that autophagy could 
play a protective role in ORI-treated HPC cells. Nu-
trient starvation has been widely used to induce au-
tophagy[26]. It is evident that viability of PC-3 cells 
with high level of autophagy induced by co-treatment 
of starvation and ORI were higher than that of cells 
treated with ORI alone. And inhibition by 3-MA in-
creased ORI-induced cell death. In addition, apoptotic 
rates of HPC cells were significantly increased after 
treatment with ORI for 48 h. Characteristic morpho-
logical features of apoptosis, such as chromatin con-
densation, nuclear fragmentation and disappearance 
of the surface microvilli were detected. These results 
indicated  that  apoptosis  was  induced  by  prolong 
treatment of ORI in HPC cells. It has been reported 
that ORI can induce apoptosis in  A431 human epi-
dermoid  carcinoma  cells[27],  HeLa  human  cervical 
carcinoma cell line[24], breast cancer cells[28], hepa-
tocelluar  carcinoma  cells[29],  and  osteosarcoma 
cells[23]. The apoptotic process was mainly associated 
with  activation  of  death  receptors,  release  of  cyto-
chrome c and cleavage of caspase through inhibition 
of the Ras/ERK and PI3K/Akt signaling pathways. It 
shows that the induction of apoptosis plays an essen-
tial role in the ORI anti-tumor activity.  So, a better 
understanding of the relationship between autophagy 
and apoptosis will help to understand the protective 
mechanism of autophagy in ORI-induced cell death.  
In our research, at 24 h, the level of autophagy 
reached its peak and a large number of autophago-
somes  were  detected.  While  apoptotic  cells  with 
sub-G0-G1 DNA content were not detected, cellular 
nuclei  and  microvilli  were  normal,  indicating  that 
HPC  cells  did  not  undergo  apoptosis  at  24  h  after 
drug  treatment.  As  the  time  was  extended  to  48  h, 
apoptotic  rates  of  HPC  cells  were  significantly  in-
creased. Typical morphological features of apoptosis, 
such as chromatin condensation, nuclear fragmenta-
tion and disappearance of the surface microvilli were 
detected. This indicates that autophagy was induced 
and  occurred  before  the  onset  of  apoptosis  in 
ORI-treated  HPC  cells.  Autophagy  preceding  apop-
tosis has also been reported in sulforaphane-treated 
prostate cancer cells[30]. Even though the connection 
between  autophagy  and  apoptotic  cell  death  is  not 
clear,  several  studies  have  demonstrated  that  both 
apoptosis and autophagy can occur concomitantly in 
the same cells under certain circumstances. In some 
studies, autophagy seems to promote apoptosis or be 
a prelude to apoptosis, and inhibition of autophagy 
inhibits DNA fragment[31]. However, in osteoblastic 
cells, a negative relationship between autophagy and 
apoptosis has been reported[32]. These negative rela-
tionships have also been observed in ORI-treated tu-
mor cells. The inhibition of autophagy could increase 
the number of apoptotic cells[6, 33, 34]. Therefore, by 
delaying the onset of apoptosis, autophagy represents 
a defense mechanism against ORI-induced cell death. 
Further research in molecular biological chemistry is 
needed  to  understand  the  relationship  between  au-
tophagy and apoptosis in prostate cancer cells.  
P21 was originally identified as a universal in-
hibitor  of  cyclin-dependent  kinases  (CDK).  But,  ac-
cumulating evidence has shown that P21 has multiple 
functions in addition to CDK inhibition including cell 
cycle regulation, inhibition or mediator of apoptotic 
signaling  pathways[35].  Previous  studies  have  re-
ported  P21  relative  to  ORI-induced  cell  cycle  arrest 
and  apoptosis  in  various  tumor  cell  lines.  ORI  has 
been  shown  to  induce  S  phase  cell  cycle  arrest  in 
MCF-7  human  breast  cancer  cells  and  G2/M  phase 
arrest  in  murine  fibrosarcoma  L929  cells  through 
up-regulating phosphorylated P53 and P21[28, 34]. In 
human laryngeal carcinoma Hep-2 cells, ORI has been 
shown to induce G2/M phase arrest and apoptosis in 
a P53-independent and P21/WAF1-dependent man-
ner[36]. ORI has also been shown to induce apoptosis 
in colorectal cancer SW1116 cells by the regulation of 
P21[37]. In our study, increased expression of P21 was 
detected  in  ORI-treated  HPC  cells  for  12  h  and 
reached maximum at 24 h. At the same time, the ex-
istence  of  a  large  number  of  autophagosomes  was 
observed in the cytoplasm under TEM. In addition, 
P21  showed  a  tendency  for  the  autophagy  marker, Int. J. Biol. Sci. 2012, 8 
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LC3-II. After 3-MA treatment, ORI-induced autoph-
agy was inhibited and the augment of P21 was also 
blocked.  Therefore,  we  speculated  that  there  was  a 
correlation between ORI-induced autophagy and P21 
expression. However, whether P21 mediate autoph-
agy signal molecules or is merely a result of autoph-
agy downstream remains to be unclear. Fujiwara et al. 
found  that  autophagy  was  not  induced  in 
ceramide-treated  P21+/+  mouse  embryonic  fibro-
blasts (MEFs). Interfere of P21 expression  increased 
autophagy.  In  ceramide-treated  P21-/-  MEFs,  there 
was a high autophagic activity, while exogenous ex-
pression of P21 decreased the number of autophagic 
cells. These results indicated that P21 played an es-
sential role in determining the type of cell death, pos-
itively  for  apoptosis  and  negatively  for  autopha-
gy[38]. So, low expression of P21 is conductive to the 
occurrence of autophagy. Elevated levels of P21 could 
be down-regulated through the reactive oxygen spe-
cies/mTOR complex 1 (ROS/mTORC1) pathway[39]. 
The mTOR pathway is an important negative regula-
tor of autophagy. With the activation of autophagy, 
the mTOR pathway is down-regulated, and the P21 
expression is promoted. The feedback regulation may 
increase  the  expression  of  P21,  which  may  further 
increase  the  number  of  apoptotic  cells.  Therefore, 
promoting  endogenous  P21  protein  expression  may 
improve cells sensitivity to ORI. 
In  summary,  we  demonstrated  that  ORI  treat-
ment could induce autophagy in HPC cells. Autoph-
agy  could  protect  cancer  cells  from  apoptotic  cell 
death by delaying the onset of apoptosis. P21 protein 
plays  an  important  role  in  ORI-induced  autophagy 
and apoptosis. The present study not only provides a 
new idea for further studying the biological activity of 
P21 and the anti-tumor mechanism of ORI, but also 
shows  that  autophagy  is  a  possible  mechanism  for 
HPC cells to resist anti-tumor agent ORI. Promoting 
endogenous expression of P21 protein may improve 
cell sensitivity to ORI. This study also provides evi-
dence for potential of ORI as a valuable component in 
therapeutic strategies to treat prostate cancer. 
Acknowledgements 
We  thank  Dr.  Tamotsu  Yoshimori  from  Osaka 
University  and  Dr.  Hanming  Shen  from  National 
University  of  Singapore  for  generous  gift  of  tfLC3 
plasmid. 
Competing Interests 
The  authors  have  declared  that  no  competing 
interest exists. 
References 
1.  Crawford ED. Epidemiology of prostate cancer. Urology. 2003; 62: 3-12. 
2.  Marks LS, DiPaola RS, Nelson P, et al. PC-SPES: herbal formulation for 
prostate cancer. Urology. 2002; 60: 369-75. 
3.  Cui Q, Tashiro S, Onodera S, et al. Augmentation of oridonin-induced 
apoptosis observed with reduced autophagy. J Pharmacol Sci. 2006; 101: 
230-9. 
4.  Cui Q, Tashiro S, Onodera S, et al. Autophagy preceded apoptosis in 
oridonin-treated  human  breast  cancer  MCF-7  cells.  Biol  Pharm  Bull. 
2007; 30: 859-64. 
5.  Li  D,  Cui  Q,  Chen  SG,  et  al.  Inactivation  of  ras  and  changes  of 
mitochondrial  membrane  potential  contribute  to  oridonin-induced 
autophagy in a431 cells. J Pharmacol Sci. 2007; 105: 22-33. 
6.  Cheng  Y,  Qiu  F,  Huang  J,  et  al.  Apoptosis-suppressing  and 
autophagy-promoting effects of calpain on oridonin-induced L929 cell 
death. Arch Biochem Biophys. 2008; 475: 148-55. 
7.  Tsujimoto Y, Shimizu S. Another way to die: autophagic programmed 
cell death. Cell Death Differ. 2005; 12 Suppl 2: 1528-34. 
8.  Terman A, Gustafsson B, Brunk UT. Autophagy, organelles and ageing. J 
Pathol. 2007; 211: 134-43. 
9.  Baehrecke EH. Autophagy: dual roles in life and death? Nat Rev Mol 
Cell Biol. 2005; 6: 505-10. 
10.  Toth S, Nagy K, Palfia Z, et al. Cellular autophagic capacity changes 
during  azaserine-induced  tumour  progression  in  the  rat  pancreas. 
Up-regulation in all premalignant stages and down-regulation with loss 
of  cycloheximide  sensitivity  of  segregation  along  with  malignant 
transformation. Cell Tissue Res. 2002; 309: 409-16. 
11.  Wu  YT,  Tan  HL,  Huang  Q,  et  al.  Autophagy  plays  a  protective  role 
during zVAD-induced necrotic cell death. Autophagy. 2008; 4: 457-66. 
12.  Tasdemir E, Chiara Maiuri M, Morselli E, et al. A dual role of p53 in the 
control of autophagy. Autophagy. 2008; 4: 810-4. 
13.  Kimura  S,  Noda  T,  Yoshimori  T.  Dissection  of  the  autophagosome 
maturation  process  by  a  novel  reporter  protein,  tandem 
fluorescent-tagged LC3. Autophagy. 2007; 3: 452-60. 
14.  Ikezoe T, Chen SS, Tong XJ, et al. Oridonin induces growth inhibition 
and apoptosis of a variety of human cancer cells. Int J Oncol. 2003; 23: 
1187-93. 
15.  Ye LH, Li WJ, Jiang XQ, et al. Study on the autophagy of prostate cancer 
PC-3 cells induced by oridonin. Anat Rec (Hoboken).2012; 295: 417-22. 
16.  Paglin S, Hollister T, Delohery T, et al. A novel response of cancer cells to 
radiation involves autophagy and formation of acidic vesicles. Cancer 
Res. 2001; 61: 439-44. 
17.  Daido S, Kanzawa T, Yamamoto A, et al. Pivotal role of the cell death 
factor BNIP3 in ceramide-induced autophagic cell death in malignant 
glioma cells. Cancer Res. 2004; 64: 4286-93. 
18.  Takeuchi H, Kondo Y, Fujiwara K, et al. Synergistic augmentation of 
rapamycin-induced  autophagy  in  malignant  glioma  cells  by 
phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res. 
2005; 65: 3336-46. 
19.  Kanzawa T, Kondo Y, Ito H, et al. Induction of autophagic cell death in 
malignant glioma cells by arsenic trioxide. Cancer Res. 2003; 63: 2103-8. 
20.  Kanzawa  T,  Germano  IM,  Komata  T,  et  al.  Role  of  autophagy  in 
temozolomide-induced  cytotoxicity  for  malignant  glioma  cells.  Cell 
Death Differ. 2004; 11: 448-57. 
21.  Cao Y, Klionsky DJ. Physiological functions of Atg6/Beclin 1: a unique 
autophagy-related protein. Cell Res. 2007; 17: 839-49. 
22.  Wu  YT,  Tan  HL,  Shui  G,  et  al.  Dual  role  of  3-methyladenine  in 
modulation of autophagy via different temporal patterns of inhibition on 
class I and III phosphoinositide 3-kinase. J Biol Chem. 2010;285: 10850-61. 
23.  Jin S, Shen JN, Wang J, et al. Oridonin induced apoptosis through Akt 
and MAPKs signaling pathways in human osteosarcoma cells. Cancer 
Biol Ther. 2007; 6: 261-8. 
24.  Hu HZ, Yang YB, Xu XD, et al. Oridonin induces apoptosis via PI3K/Akt 
pathway in cervical carcinoma HeLa cell line. Acta Pharmacol Sin. 2007; 
28: 1819-26. 
25.  Cui  Q,  Tashiro  S,  Onodera  S,  et  al.  Oridonin  induced  autophagy  in 
human  cervical  carcinoma  HeLa  cells  through  Ras,  JNK,  and  P38 
regulation. J Pharmacol Sci. 2007; 105: 317-25. 
26.  Martinez-Borra J, Lopez-Larrea C. Autophagy and self-defense. Adv Exp 
Med Biol. 2012; 738: 169-84. 
27.  Mei  Y,  Xu  J,  Zhao  J,  et  al.  An  HPLC  method  for  determination  of 
oridonin  in  rabbits  using  isopsoralen  as  an  internal  standard  and  its 
application  to  pharmacokinetic  studies  for  oridonin-loaded 
nanoparticles. J Chromatogr B Analyt Technol Biomed Life Sci. 2008; 869: 
138-41. Int. J. Biol. Sci. 2012, 8 
 
http://www.biolsci.org 
912 
28.  Cui Q, Yu JH, Wu JN, et al. P53-mediated cell cycle arrest and apoptosis 
through a caspase-3- independent, but caspase-9-dependent pathway in 
oridonin-treated MCF-7 human breast cancer cells. Acta Pharmacol Sin. 
2007; 28: 1057-66. 
29.  Zhang  JF,  Chen  GH,  Lu  MQ,  et  al.  Change  of  Bcl-2  expression  and 
telomerase  during  apoptosis  induced  by  oridonin  on  human 
hepatocelluar carcinoma cells. Zhongguo Zhong Yao Za Zhi. 2006; 31: 
1811-4. 
30.  Herman-Antosiewicz  A,  Johnson  DE,  Singh  SV.  Sulforaphane  causes 
autophagy to inhibit release of cytochrome C and apoptosis in human 
prostate cancer cells. Cancer Res. 2006; 66: 5828-35. 
31.  Jia  L,  Dourmashkin  RR,  Allen  PD,  et  al.  Inhibition  of  autophagy 
abrogates  tumour  necrosis  factor  alpha  induced  apoptosis  in  human 
T-lymphoblastic leukaemic cells. Br J Haematol. 1997; 98: 673-85. 
32.  Lai EH, Hong CY, Kok SH, et al. Simvastatin alleviates the progression of 
periapical  lesions  by  modulating  autophagy  and  apoptosis  in 
osteoblasts. J Endod. 2012; 38: 757-63. 
33.  Cui Q, Tashiro S, Onodera S, et al. Mechanism of downregulation of 
apoptosis by autophagy induced by oridonin in HeLa cells. Yao Xue Xue 
Bao. 2007; 42: 35-9. 
34.  Cheng  Y,  Qiu  F,  Ye  YC,  et  al.  Autophagy  inhibits  reactive  oxygen 
species-mediated  apoptosis  via  activating  p38-nuclear  factor-kappa  B 
survival pathways in oridonin-treated murine fibrosarcoma L929 cells. 
Febs J. 2009; 276: 1291-306. 
35.  Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor 
p21 in apoptosis. Mol Cancer Ther. 2002; 1: 639-49. 
36.  Kang  C,  Avery  L.  To  be  or  not  to  be,  the  level  of  autophagy  is  the 
question: dual roles of autophagy in the survival response to starvation. 
Autophagy. 2008; 4: 82-4. 
37.  Gao FH, Hu XH, Li W, et al. Oridonin induces apoptosis and senescence 
in  colorectal  cancer  cells  by  increasing  histone  hyperacetylation  and 
regulation of p16, p21, p27 and c-myc. BMC Cancer. 2010;10: 610. 
38.  Fujiwara  K,  Daido  S,  Yamamoto  A,  et  al.  Pivotal  role  of  the 
cyclin-dependent  kinase  inhibitor  p21WAF1/CIP1  in  apoptosis  and 
autophagy. J Biol Chem. 2008; 283: 388-97. 
39.  Ji WT, Yang SR, Chen JY, et al. Arecoline downregulates levels of p21 
and p27 through the reactive oxygen species/mTOR complex 1 pathway 
and may contribute to oral squamous cell carcinoma. Cancer Sci. 2012; 
Epub ahead of print. 